TRAVERE THERAPEUTICS INC - NOTE 2.500% 9/1

Historical Portfolio Holders from Q3 2018 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Debt / NOTE 2.500% 9/1
Principal, excl. options Q1 2024
64.4 M
Holdings value Q1 2024
$57 M
Value change Q1 2024
-$307 K
Grand Portfolio weight change Q1 2024
0%
Number of holders
5
Number of buys Q1 2024
1
Number of sells Q1 2024
-1
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
761299AB2
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Principal Value Change Price Investors
2024 Q1 $64.4 M $57 M -$307 K $0.88 5
2023 Q4 $64.9 M $55.2 M $0 $0.85 6
2023 Q3 $67.8 M $58.2 M $0 $0.85 7
2023 Q2 $67.8 M $60.9 M -$11.4 K $0.89 7
2023 Q1 $67.7 M $65.1 M +$235 K $0.95 6
2022 Q4 $67.7 M $62.5 M -$9.74 M $0.92 8
2022 Q3 $24.5 M $24.7 M -$3.98 M $1.01 8
2022 Q2 $28.5 M $28.1 M -$34.8 M $0.99 9
2022 Q1 $67.6 M $64.7 M -$689 M $1.03 22
2021 Q4 $281 M $758 M -$1.12 M $1.09 31
2021 Q3 $283 M $715 M +$34.2 M $1.01 34
2021 Q2 $247 M $581 M +$2.79 M $0.85 34
2021 Q1 $246 M $704 M -$12 B $1.02 32
2020 Q4 $274 M $663 M +$3.46 M $1.01 31
2020 Q3 $277 M $579 M +$8.78 M $0.85 35
2020 Q2 $255 M $512 M -$4.73 M $0.82 35
2020 Q1 $270 M $196 M +$30.8 M $0.78 38
2019 Q4 $236 M $169 M +$881 K $0.78 32
2019 Q3 $236 M $161 M +$1.31 M $0.74 31
2019 Q2 $219 M $189 M -$2.48 M $0.90 34
2019 Q1 $215 M $199 M +$1.58 M $0.93 31
2018 Q4 $212 M $189 M -$21.8 M $0.90 29
2018 Q3 $223 M $229 M +$229 M $1.02 29